However, tumor cells express programmed death-1 (PD-1) ligands (PD-L1/PD-L2) on the surface, inhibit the activation of T cells, and induce the immune tolerance of tumor cells by the binding of PD-L1 to the PD-1 expressed on T cells. This evidence concerns the gene PDCD1LG2 and neoplasm.